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showed a significant correlation (~~~-r=.96; SBP-r=.96; DBPi n f a n t s showed s i g n i f i c a n t improvement (p<.010) when treated w i t h r=.98) and slope not significantly different from 1. Average furosemide. There were no s i g n i f i c a n t differences between responvalues of the mean differences between peripheral and IA BP were ders (n=20) and nonresponders (n=8) i n mean gestational age near zero'(n=279; MBP=0.5; SBP=0.2; DBP=~.~). Analysis of vari-(28.2 vs 28.5 wks) , b i r t h weight, male-female d i s t r i b u t i o n , age ance of the individual peripheral -IA differences showed siga t s t a r t o f study, o r type o f chronic lung disease. 12/20 nificant variability within and between patients (p<.001). Over-' responders had a s i g n i f i c a n t d e t e r i o r a t i o n i n t h e i r respiratory all, the within patient variability (+sD) was 12, 16 and 13 torr scores when therapy was discontinued. 21/28 received a second for MBP, SBP and DBP respectively. Between patient variability t r i a l o f furosemide: 14/21 responded t o retreatment. An i n f a n t ' s was only slightly lower. response i n the second t r i a l was independent o f h i s response i n
In conclusion, when a series of measurements are made & averaged, the f i r s t t r i a l . B r i e f periods o f furosemide therapy may be usethe automatic sphygomomanometer correlates well with IA BP and f u l i n the management o f chronic lung disease i n some preterm could be useful for the longitudinal monitoring of sick NB. HOWinfants, but prolonged continuous use needs further evaluatlon.
ever, using only a few eripheral determinations could be misleading in estimating tae IA BP, due to the larae variability. 28.2%, and A0 pressure increased by 3.1 + 8.3%. At all doses PVR (7.0%) with NT tubes (NS). Bacterial colonization occurred in fell further than systemic vascular resistance (SVR). At the 20 18.6% in the OT group and 39.5% in the NT group, but the differug dose PVR fell by 51.9 + 13.3% while, SVR fell by 29.2 + 12.5% ence was not statistically significant. Other problems occurred due to the large increase in CO. Under these conditions PGD2 has in 10 infants: 2 could not be nasally intubated; 4 with NT tubes a powerful and specific effect on PVR. This specificity may be developed nasal erosions; 3 babies with OT tubes developed palimportant in the regulation of PVR at birth and in treatment of atal grooves. This study suggests that NT tubes offer no advanpersistent pulmonary hypertension.
tages over OT tubes in the neonatal period, either for stability or frequency of complications. Different therapeutic modalities affected COP widely. Crystalloid infusion (10-20ccIkg) decreased COP by 22% and surgery by 32%. COP increased 63% after exchange transfusion, 23% after infusion of plasma (10-20cc/kg) and 15% one hour after Furosemide administration.
COLLOID OSMOTIC PRESSURE OF NORMAL NEWBORNS
We conclude that COP varies not only with gestational age but also with mode of delivery, experience of labor and therapy. In critically ill preterm neonates, since estimations from TP are inadequate, the only way to obtain a quantitative measure of COP is by direct measurement. Repeated COP measurements will permit precise selection of fluid therapy and warn of changes that may lead to pulmonary edema. To determine whether a particular type of endotracheal (ET) tube plays a role in post-extubation atelectasis, 86 consecutive admissions to the IICU of The Children's Hospital of Philadelphia were prospectively studied. All required >48 hrs, intubation. The infants were admitted for the following conditions: 70(81.4%)-respiratory distress syndrome; 5(5.8%)-apnea; 4(4.6%)-birth asphyxia; 3(3.5%)-persistent pulmonary hypertension; 3 (3.5%)-sepsis; 1(1.2%)-congenital anomalies (non-respiratory). Infants were assigned randomly to either an oral (OT) or nasal (NT) endotracheal tube for their entire hospitalization. Mean birthweights were: OT 1895512 SEM gms.; NT 1903543 SEM gms. (NS). Mean gestational ages were: OT 32.1+.6 SEM wks.; NT 32.9 +.5 SEM wks. (NS). Fifteen of 43 (34.9%) of infants in the NT -group developed post-extubation segmental or lobar atelectasis, whereas 5/43 (11.6%) of infants in the OT group had post-extubation atelectasis (p<.025). Eleven of the NT babies (25.6%) and five (11.6%) of the OT babies required reintubation (NS). This study suggests that nasal ET tubes result in a significantly increased incidence of post-extubation atelectasis in the neonate as compared to oral ET tubes. Since the human newborn is an obligate nose breather, nasal intubation for greater than 48 hrs may lead to significant edema and increased upper airway resistance after extubation. Oral ET tubes, especially for the premature baby with RDS, may therefore be the preferred route of intubation.
